In the midst of a national debate over the influence of industry money on medical research and practice, the drug maker Eli Lilly says it will begin publicly reporting all of its payments to outside doctors for speaking and consulting services. The company’s chief executive, John C. Lechleiter, announced on Wednesday that starting next year it intends to post all its payments to doctors in an online database. The posting will “likely include” the name of the doctor or some other identifying information, along with the reason for the payment, the company said. Members of Congress have been pushing for a national registry of such payments.
Steve - I'll believe it when I see it.